SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?


To: Scott H. Davis who wrote (9711)7/9/1998 10:12:00 PM
From: Stephen Smith  Read Replies (1) | Respond to of 14328
 
I have appreciated the contributions of most of the people on this
board. I have been long on TRIBY for two years and have averaged
down on dips, usually during the end of year tax selling. I am
concerned that revenues only seem to grow through acquisitions.
The internal growth rate is hard to judge but does not seem very
robust. I have talked with management several times and they have
always been friendly and informative. Trinity seems to have great
products but I think their marketing of the products could be
much better. They have some good partnerships like SKB in Africa
but they are going to have to do more to grow sales. I pressed
for a $ figure for the Malaysia HIV agreement and was told that
they expected to do about one million in sales this year under the
agreement, BUT that the economic problems in Asia might cut into
that. I would expect that HIV test sales in Africa via SKB will
increase as SKB starts selling it in more countries. My patience
is starting to wear thin but I won't sell at this price. A long
time lurker says Hi! to Keiko, Ron, Leman, Scott, Caroline
and Daughters and everyone else. It was hot and steamy here in
North Carolina today.